These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34627511)

  • 1. The importance of being metal-free: The critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry.
    Murisier A; Fekete S; Guillarme D; D'Atri V
    Anal Chim Acta; 2021 Oct; 1183():338987. PubMed ID: 34627511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products.
    Murisier A; Andrie M; Fekete S; Lauber M; D'Atri V; Iwan K; Guillarme D
    J Sep Sci; 2022 Jun; 45(12):1997-2007. PubMed ID: 35278285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins.
    Goyon A; Fekete S; Beck A; Veuthey JL; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():368-378. PubMed ID: 29936373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size Exclusion and Ion Exchange Chromatographic Hardware Modified with a Hydrophilic Hybrid Surface.
    Fekete S; DeLano M; Harrison AB; Shiner SJ; Belanger JL; Wyndham KD; Lauber MA
    Anal Chem; 2022 Feb; 94(7):3360-3367. PubMed ID: 35143179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation.
    Goyon A; D'Atri V; Colas O; Fekete S; Beck A; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():35-43. PubMed ID: 28946123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size-exclusion chromatography using reverse-phase columns for protein separation.
    Huang TY; Chi LM; Chien KY
    J Chromatogr A; 2018 Oct; 1571():201-212. PubMed ID: 30146374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Removal of metallic impurities from mobile phases in reversed-phase high-performance liquid chromatography by the use of an in-line chelation column.
    Slingsby RW; Bordunov A; Grimes M
    J Chromatogr A; 2001 Apr; 913(1-2):159-63. PubMed ID: 11355809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies.
    Xu CF; Zang L; Weiskopf A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():230-8. PubMed ID: 24835510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
    Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extending the limits of size exclusion chromatography: Simultaneous separation of free payloads and related species from antibody drug conjugates and their aggregates.
    Goyon A; Sciascera L; Clarke A; Guillarme D; Pell R
    J Chromatogr A; 2018 Mar; 1539():19-29. PubMed ID: 29397979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of size exclusion chromatography columns packed with sub-3μm particles for the analysis of biopharmaceutical proteins.
    Goyon A; Beck A; Colas O; Sandra K; Guillarme D; Fekete S
    J Chromatogr A; 2017 May; 1498():80-89. PubMed ID: 27914608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution separation of recombinant monoclonal antibodies by size-exclusion ultra-high performance liquid chromatography (SE-UHPLC).
    Yang R; Tang Y; Zhang B; Lu X; Liu A; Zhang YT
    J Pharm Biomed Anal; 2015 May; 109():52-61. PubMed ID: 25766848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of interactions between antibody biotherapeutics and copper by size exclusion chromatography (SEC) coupled with inductively coupled plasma mass spectrometry (ICP/MS).
    Luo Y; Ronk M; Joubert MK; Semin D; Nashed-Samuel Y
    Anal Chim Acta; 2019 Nov; 1079():252-259. PubMed ID: 31387718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive study on the effects of sodium and potassium additives in size exclusion chromatographic separations of protein biopharmaceuticals.
    Goyon A; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2017 Sep; 144():242-251. PubMed ID: 27697310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-depth size and charge variants characterization of monoclonal antibody with native mass spectrometry.
    Dai J; Ji C
    Anal Chim Acta; 2023 Jul; 1265():341360. PubMed ID: 37230578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Size exclusion chromatography of biopharmaceutical products: From current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles.
    D'Atri V; Imiołek M; Quinn C; Finny A; Lauber M; Fekete S; Guillarme D
    J Chromatogr A; 2024 May; 1722():464862. PubMed ID: 38581978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity profiling of monoclonal antibody and antibody-drug-conjugate preparations by coupled liquid chromatography-surface plasmon resonance biosensing.
    Lakayan D; Haselberg R; Gahoual R; Somsen GW; Kool J
    Anal Bioanal Chem; 2018 Dec; 410(30):7837-7848. PubMed ID: 30328504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microflow size exclusion chromatography to preserve micromolar affinity complexes and achieve subunit separations for native state mass spectrometry.
    Hecht ES; Obiorah EC; Liu X; Morrison L; Shion H; Lauber M
    J Chromatogr A; 2022 Dec; 1685():463638. PubMed ID: 36379198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of column hardware on liquid chromatography-mass spectrometry of phosphorylated compounds.
    Sakamaki H; Uchida T; Lim LW; Takeuchi T
    J Chromatogr A; 2015 Feb; 1381():125-31. PubMed ID: 25604270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
    Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.